Suppr超能文献

细胞铁代谢与调控。

Cellular Iron Metabolism and Regulation.

机构信息

Laboratory of Molecular Iron Metabolism, College of Life Sciences, Hebei Normal University, Shijiazhuang, Hebei Province, China.

出版信息

Adv Exp Med Biol. 2019;1173:21-32. doi: 10.1007/978-981-13-9589-5_2.

Abstract

Iron is an essential trace element in the human body, but excess iron is toxic as it contributes to oxidative damage. To keep iron concentration within the optimal physiologic range, iron metabolism at the cellular level and the whole systemic level are tightly regulated. Balance of iron homeostasis depends on the expression levels and activities of iron carriers, iron transporters, and iron regulatory and storage proteins. Divalent metal transporter 1 (DMT1) at the apical membrane of intestinal enterocyte brings in non-heme iron from the diet, whereas ferroportin 1 (FPN1) at the basal membrane exports iron into the circulation. Plasma transferrin (Tf) then carries iron to various tissues and cells. After binding to transferrin receptor 1 (TfR1), the complex is endocytosed into the cell, where iron enters the cytoplasm via DMT1 on the endosomal membrane. Free iron is either utilized in metabolic processes, such as synthesis of hemoglobin and Fe-S cluster, or sequestered in the cytosolic ferritin, serving as a cellular iron store. Excess iron can be exported from the cell via FPN1. The liver-derived peptide hepcidin plays a major regulatory role in controlling FPN1 level in the enterocyte, and thus controls the whole-body iron absorption. Inside the cells, iron regulatory proteins (IRPs) modulate the expressions of DMT1, TfR1, ferritin, and FPN1 via binding to the iron-responsive element (IRE) in their mRNAs. Both the release of hepcidin and the IRP-IRE interaction are coordinated with the fluctuation of the cellular iron level. Therefore, an adequate and steady iron supplement is warranted for the utilization of cells around the body. Investigations on the molecular mechanisms of cellular iron metabolism and regulation could advance the fields of iron physiology and pathophysiology.

摘要

铁是人体必需的微量元素,但过量的铁是有毒的,因为它会导致氧化损伤。为了将铁浓度保持在最佳生理范围内,细胞水平和全身系统水平的铁代谢都受到严格调节。铁平衡的平衡取决于铁载体、铁转运蛋白、铁调节和储存蛋白的表达水平和活性。肠上皮细胞顶膜上的二价金属转运蛋白 1(DMT1)从饮食中摄取非血红素铁,而基底膜上的铁蛋白 1(FPN1)将铁输出到循环中。然后,血浆转铁蛋白(Tf)将铁携带到各种组织和细胞。与转铁蛋白受体 1(TfR1)结合后,该复合物被内吞到细胞中,铁通过内体膜上的 DMT1 进入细胞质。游离铁要么用于代谢过程,如血红蛋白和 Fe-S 簇的合成,要么被隔离在细胞质中的铁蛋白中,作为细胞内的铁储存。多余的铁可以通过 FPN1 从细胞中输出。肝脏衍生的肽素在控制肠上皮细胞中 FPN1 水平方面发挥主要调节作用,从而控制全身铁吸收。在细胞内,铁调节蛋白(IRP)通过结合其 mRNA 中的铁反应元件(IRE)来调节 DMT1、TfR1、铁蛋白和 FPN1 的表达。肝素有释放和 IRP-IRE 相互作用都与细胞内铁水平的波动相协调。因此,身体周围的细胞需要足够和稳定的铁补充。对细胞铁代谢和调节的分子机制的研究可以促进铁生理学和病理生理学领域的发展。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验